Insmed to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on Thursday, February 20, 2025
Insmed (Nasdaq: INSM) has announced it will release its fourth-quarter and full-year 2024 financial results on Thursday, February 20, 2025. The company will host a conference call for investors at 8:00 a.m. ET on the same day to discuss the results and provide a business update.
Participants can join the call by dialing (888) 210-2654 (U.S.) or (646) 960-0278 (international) using access code 7862189. The call will be webcast live on Insmed's website. A replay will be available until February 27, 2025, through both dial-in and webcast options, with the webcast archived for 90 days on the company's website.
Insmed (Nasdaq: INSM) ha annunciato che rilascerà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 giovedì 20 febbraio 2025. L'azienda ospiterà una conferenza telefonica per gli investitori alle 8:00 ET lo stesso giorno per discutere i risultati e fornire un aggiornamento aziendale.
I partecipanti possono unirsi alla chiamata componendo il numero (888) 210-2654 (USA) o (646) 960-0278 (internazionale) utilizzando il codice di accesso 7862189. La chiamata sarà trasmessa in diretta sul sito web di Insmed. Una registrazione sarà disponibile fino al 27 febbraio 2025, sia tramite chiamata che opzioni di webcast, con il webcast archiviato per 90 giorni sul sito web dell'azienda.
Insmed (Nasdaq: INSM) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 el jueves 20 de febrero de 2025. La empresa llevará a cabo una conferencia telefónica para inversores a las 8:00 a.m. ET el mismo día para discutir los resultados y proporcionar una actualización del negocio.
Los participantes pueden unirse a la llamada marcando el (888) 210-2654 (EE. UU.) o (646) 960-0278 (internacional), usando el código de acceso 7862189. La llamada se transmitirá en vivo en el sitio web de Insmed. Una repetición estará disponible hasta el 27 de febrero de 2025, tanto a través de llamada como de opciones de webcast, con el webcast archivado durante 90 días en el sitio web de la empresa.
인스메드 (Nasdaq: INSM)는 2025년 2월 20일(목)에 2024년 4분기 및 연간 재무 결과를 발표할 것이라고 발표했습니다. 회사는 같은 날 오전 8시(동부 표준시)에 투자자를 위한 컨퍼런스 콜을 개최하여 결과를 논의하고 비즈니스 업데이트를 제공할 예정입니다.
참석자는 (888) 210-2654 (미국) 또는 (646) 960-0278 (국제)로 전화하여 접근 코드 7862189를 사용하여 전화를 받을 수 있습니다. 이 통화는 인스메드 웹사이트에서 실시간으로 방송될 예정입니다. 재생은 2025년 2월 27일까지 전화 및 웹캐스트 옵션을 통해 사용할 수 있으며, 웹캐스트는 회사 웹사이트에서 90일 동안 보관됩니다.
Insmed (Nasdaq: INSM) a annoncé qu'il publiera ses résultats financiers du quatrième trimestre et de l'année complète 2024 le jeudi 20 février 2025. L'entreprise organisera un appel de conférence pour les investisseurs à 8h00 ET le même jour pour discuter des résultats et fournir une mise à jour sur l'activité.
Les participants peuvent rejoindre l'appel en composant le (888) 210-2654 (États-Unis) ou le (646) 960-0278 (international) en utilisant le code d'accès 7862189. L'appel sera diffusé en direct sur le site web d'Insmed. Un replay sera disponible jusqu'au 27 février 2025, à la fois par téléphone et par options de webcast, avec le webcast archivé pendant 90 jours sur le site web de l'entreprise.
Insmed (Nasdaq: INSM) hat bekannt gegeben, dass es am Donnerstag, den 20. Februar 2025, seine Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 8:00 Uhr ET eine Telefonkonferenz für Investoren abhalten, um die Ergebnisse zu erörtern und ein Unternehmensupdate zu geben.
Teilnehmer können sich der Konferenz anschließen, indem sie (888) 210-2654 (USA) oder (646) 960-0278 (international) wählen und den Zugangscode 7862189 verwenden. Die Konferenz wird live auf der Website von Insmed übertragen. Eine Wiederholung wird bis zum 27. Februar 2025 sowohl über die Telefonleitung als auch die Webcast-Optionen verfügbar sein, wobei der Webcast 90 Tage lang auf der Unternehmenswebsite archiviert wird.
- None.
- None.
Insmed management will host a conference call for investors beginning at 8:00 a.m. ET on Thursday, February 20, 2025, to discuss financial results and provide a business update.
Shareholders and other interested parties may participate in the conference call by dialing (888) 210-2654 (
A replay of the conference call will be accessible approximately 1 hour after its completion through February 27, 2025, by dialing (800) 770-2030 (
About Insmed
Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including a therapy approved in
Headquartered in
Contact:
Investors:
Bryan Dunn
Vice President, Investor Relations
(646) 812-4030
bryan.dunn@insmed.com
Michael V. Morabito, Ph.D.
Director, Investor Relations
(917) 936-8430
michael.morabito@insmed.com
Gianna De Palma
Manager, Investor Relations
(973) 886-2236
gianna.depalma@insmed.com
Media:
Mandy Fahey
Vice President, Corporate Communications
(732) 718-3621
amanda.fahey@insmed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-host-fourth-quarter-and-full-year-2024-financial-results-conference-call-on-thursday-february-20-2025-302371620.html
SOURCE Insmed Incorporated
FAQ
When will Insmed (INSM) release its Q4 and full-year 2024 earnings?
What time is Insmed's (INSM) Q4 2024 earnings call?
How can investors access Insmed's (INSM) Q4 2024 earnings call?
How long will Insmed's (INSM) Q4 2024 earnings call replay be available?
